Global Cystic Fibrosis Therapeutics Market to grow at a CAGR of 31.9% during 2016-2020

About Cystic Fibrosis

Cystic fibrosis, also known as mucoviscidosis, is a genetically inherited, chronic disease and is progressive in nature. The onset of cystic fibrosis typically occurs in early childhood or, rarely, at birth. The primary symptoms of cystic fibrosis include breathing difficulties, high salt content in the sweat, and secretion of abnormally viscous mucus. The principal indicators of cystic fibrosis in patients are pancreatic insufficiency, pancreatitis, chronic bronchitis, adolescent diabetes, male sterility, and very rarely liver cirrhosis or intestinal obstruction. The most usual forms of cystic fibrosis are those with respiratory complications, difficulties related to digestion, and anomalies in height and growth. The mortality and morbidity of a patient are dependent on the degree of bronchopulmonary involvement.

Technavios analysts forecast the global cystic fibrosis therapeutics market to grow at a CAGR of 31.9% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global cystic fibrosis therapeutics market for 2016-2020. The report has taken into consideration the revenue generated by the vendors in the PET packaging market for packaging of different goods.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Cystic Fibrosis Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Download Sample copy of Report at http://www.marketresearchreports.biz/sample/sample/840956

Key vendors
AbbVie
F. Hoffmann-La Roche
Gilead Sciences
Novartis
Vertex Pharmaceuticals

Other prominent vendors
Advanced Inhalation Therapies (AIT)
Alaxia SAS
Alcresta Therapeutics
AlgiPharma
Allergan
Anthera
AstraZeneca
Bayer
Celtaxsys
Chiesi Farmaceutici
Corbus Pharmaceuticals
Cyclacel Pharmaceuticals
Digestive Care
Galapagos
Grifols
Insmed Incorporated
Kamada
Nivalis Therapeutics
Novoteris
Parion Sciences
Pharmaxis
ProQR Therapeutics
Protalix Biotherapeutics
Proteostasis Therapeutics
PTC Therapeutics
Pulmatrix
Savara
SolAeroMed
Vectura

Market driver
Special regulatory designations for drugs
For a full, detailed list, view our report

Market challenge
Discontinuation of drugs from development
For a full, detailed list, view our report

Market trend
Co-pay and assistance programs by vendors
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Email: sales@marketresearchreports.biz

This release was published on openPR.